These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10869379)

  • 1. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism.
    Chen Y; Buck J
    J Pharmacol Exp Ther; 2000 Jun; 293(3):807-12. PubMed ID: 10869379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.
    McAllister SD; Chan C; Taft RJ; Luu T; Abood ME; Moore DH; Aldape K; Yount G
    J Neurooncol; 2005 Aug; 74(1):31-40. PubMed ID: 16078104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
    Derocq JM; Ségui M; Marchand J; Le Fur G; Casellas P
    FEBS Lett; 1995 Aug; 369(2-3):177-82. PubMed ID: 7544292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
    Hampson AJ; Grimaldi M; Axelrod J; Wink D
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8268-73. PubMed ID: 9653176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats.
    Hampson RE; Deadwyler SA
    J Neurosci; 2000 Dec; 20(23):8932-42. PubMed ID: 11102504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.
    Gilbert GL; Kim HJ; Waataja JJ; Thayer SA
    Brain Res; 2007 Jan; 1128(1):61-9. PubMed ID: 17140550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
    Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
    Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
    Tomiyama K; Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats.
    Robinson L; Hinder L; Pertwee RG; Riedel G
    Psychopharmacology (Berl); 2003 Feb; 166(1):40-50. PubMed ID: 12488948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes.
    Kaplan BL; Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1077-85. PubMed ID: 12805480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
    Fan F; Compton DR; Ward S; Melvin L; Martin BR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1383-90. PubMed ID: 7996450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
    Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
    Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.